The Parkinson Progression Marker Initiative (PPMI)Kenneth Marek, Marne Baca, Danna Jennings et al.|Progress in Neurobiology|2011Cited by 1.9k
Phosphorylated α-Synuclein in Parkinson’s DiseaseYu Wang, Jing Zhang, Min Shi et al.|Science Translational Medicine|2012Cited by 277
<sup>18</sup>F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R. Schonhaut, Gil D. Rabinovici, Lea T. Grinberg et al.|Annals of Neurology|2017Cited by 175
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesDaniela Berg, Matthew Stern, Anthony E. Lang et al.|The Lancet Neurology|2013Cited by 156
Research on the Premotor Symptoms of Parkinson’s Disease: Clinical and Etiological ImplicationsHonglei Chen, Jing Zhang, Edward A. Burton et al.|Environmental Health Perspectives|2013Cited by 81